ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting Spinal Ependymoma and Other Gliomas Using Novel Genetically Defined Models||The Johns Hopkins University School of Medicine / Charles Eberhart, MD, PhD||Catalyst Grants||2019||Maryland|
|Practical, Reproducible, and Statistically-Rigorous Workflows for Single-Nucleus Analysis of Childhood Cancer Data||Johns Hopkins Bloomberg School of Public Health / Stephanie C. Hicks, PhD||Crazy 8 Pilots||2019||Maryland|
|Targeting Fusion-driven Sarcomas||National Institutes of Health / Javed Khan, MD||Crazy 8 Pilots||2019||Maryland|
|Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities||Dana-Farber Cancer Institute / Mariella Filbin, MD/PhD||'A' Award Grants||2019||Massachusetts|
|Single-cell Atlas of Pediatric Osteosarcoma||Dana-Farber Cancer Institute / Natalie Collins, MD/PhD||Single-cell Pediatric Cancer Atlas Grant||2019||Massachusetts|
|The Impact Of CD56neg NK Cells in the Pathogenesis of Endemic Burkitt Lymphoma||University of Massachusetts Medical School / Catherine Forconi, PhD||Young Investigator Grants||2019||Massachusetts|
|Targeted Hyperactivation of PI3K/AKT in B-cell malignancies||Dana-Farber Cancer Institute / Vishal Khairnar, PhD||Young Investigator Grants||2019||Massachusetts|
|Targeting symmetric division in pediatric cancers||Dana-Farber Cancer Institute / Rosalind Segal, MD/PhD||Innovation Grants||2019||Massachusetts|
|Epigenetic regulation of genomic instability and its therapeutic implications in T-cell acute lymphoblastic leukemia||Dana-Farber Cancer Institute / Birgit Knoechel, MD/PhD||Innovation Grants||2019||Massachusetts|
|Selectively targeting EP300 with small molecules for neuroblastoma (NB) therapy||Dana-Farber Cancer Institute / Jun Qi, PhD||Innovation Grants||2019||Massachusetts|